Work

Abstract PD3-16: Clinical safety and efficacy of the aurora and angiogenic kinase inhibitor ENMD-2076 in previously treated, locally advanced or metastatic triple-negative breast cancer

Year: 2018

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs17-pd3-16

Authors: JR Diamond, SG Eckhardt, TM Pitts, A van Bokhoven, D Aisner, DL Gustafson, A Capasso, AD Elias, AM Storniolo, BP Schneider, D Gao, JJ Tentler, VF Borges, KD Miller

Institutions: University of Colorado Cancer Center, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, University of Colorado Anschutz, Indiana University, The University of Texas at Austin

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2790762652

Cites:

Cited by: 2

Related to: 10